In China's first-ever securities class action, Kangmei Pharmaceuticals has been ordered to pay $385 million as compensation—just enough for 50,000 investors to recoup their losses.
November 22, 2021
Capital Markets
Hong Kong IPOs also subject to cybersecurity review; social, sustainability bond issuance pilot for foreign issuers; and U.S. law bars new equipment licenses for Chinese telecoms firms
November 16, 2021SEC approves framework for implementing U.S. delisting law; HKEX releases guidance for issuers' climate disclosures; and China, EU unveil joint green investment taxonomy
November 08, 2021HKEX launches its first A-share futures contract for global investors; Goldman Sachs approved to take full control of securities business; and Wealth Connect kicks off with 19 eligible banks
October 25, 2021LinkedIn announces "sunset" of its Chinese platform; Weak Q3 GDP signals a challenging road to economic recovery; Additional capital and leverage ratio requirements for 19 Domestic Systematically Important Banks
October 18, 2021Southbound trading launched for Bond Connect between mainland China and Hong Kong
October 15, 2021From antitrust to securities laws, being the general counsel of a major real estate brokerage platform requires a generalist skillset
September 30, 2021PBOC reaffirms nationwide ban on cryptocurrencies and related transactions; President Xi announces pause on coal-fired projects abroad; and PCAOB adopts final rule to implement US delisting regime
September 28, 2021The HKEX has published a consultation paper to introduce its SPAC listing regime; US-China bilateral tech investment plummets 96%; and MIIT calls on telecoms and auto companies to strengthen data protection policies.
September 20, 2021
